Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-37,300
Closed -$2.02M – 3477
2016
Q3
$2.02M Hold
37,300
– – ﹤0.01% 1918
2016
Q2
$1.7M Buy
+37,300
New +$1.82M ﹤0.01% 2042
2016
Q1
– Sell
-8,831
Closed -$355K – 3512
2015
Q4
$355K Buy
+8,831
New +$405K ﹤0.01% 3280
2015
Q1
– Sell
-6,682
Closed -$593K – 3721
2014
Q4
$593K Buy
6,682
+872
+15% +$79K ﹤0.01% 3202
2014
Q3
$570K Sell
5,810
-31,955
-85% -$3.59M ﹤0.01% 3249
2014
Q2
$4.84M Buy
37,765
+5,810
+18% +$726K 0.01% 1653
2014
Q1
$3.92M Buy
+31,955
New +$3.67M 0.01% 1770
2013
Q4
– Sell
-30,503
Closed -$2.97M – 4515
2013
Q3
$2.97M Sell
30,503
-11,620
-28% -$1.07M ﹤0.01% 2077
2013
Q2
$3.78M Buy
+42,123
New +$3.47M 0.01% 1571

Other funds holding ENOV

David Shaw's ENOV Position: Q3 2026 in Review

David Shaw increased its Enovis (ENOV) stake by 30% in Q3 2026, buying an estimated $600K and bringing the position to 108,999 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #3246.

David Shaw first reported a position in ENOV in Q2 2013 and has held it in 47 quarters since. The position peaked at $27.3M in Q2 2013. 244 funds tracked by Wall St. Rank hold ENOV as of Q3 2026.

  • David Shaw held 108,999 shares of Enovis worth $1.99M as of Q3 2026.
  • David Shaw bought 25,203 Enovis shares in Q3 2026, an estimated $600K.
  • Enovis made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #3246 holding.
  • David Shaw first reported a position in Enovis in Q2 2013 and has held it in 47 quarters since.
  • David Shaw's Enovis position peaked at $27.3M in Q2 2013.
  • 244 funds tracked by Wall St. Rank held Enovis as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.